Drugs, Neurologist Stores: "With Modified-Release Formulation Minus Parkinson's Tablets"
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.8 Articles
8 Articles
Il Tempo
Rome, 2 sets. (Adnkronos Salute) - The new formulation of modified-release levodopa-carbidopa has a very interesting pharmaceutical engineering, because this pill is able to release one part immediately, 25% of levodopa, so the patient has the rapid effect of the tablet within half an hour, three quarters of an hour. The other part of the formulation is made up of pellets that are slowly released into the small intestine: this means that the pla…
A slow-release formulation with a very interesting pharmaceutical engineering. Fabrizio Stocks, neurologist, University and IRCSS San Raffaele of Rome illustrates the characteristics of the new combination levodopa/carbidopa, for the treatment of Parkinson's, able to combine a rapid effect with a prolonged release of the drug. A mechanism that could reduce the number of daily doses and maintain more stable levels of levodopa, with a significant …
The new formulation of modified-release levodopa-carbidopa has a very interesting pharmaceutical engineering, because this pill is able to release one part immediately, 25% of levodopa, so the patient has the rapid effect of the tablet within half an hour, three quarters of an hour. The other part of the formulation is made up of pellets that are [...]
Rec News | Lontani dal mainstream
notizie.itA slow-release formulation with a very interesting pharmaceutical engineering. Fabrizio Stocks, neurologist, University and IRCSS San Raffaele of Rome illustrates the characteristics of the new combination levodopa/carbidopa, for the treatment of Parkinson's, able to combine a rapid effect with a prolonged release of the drug. A mechanism that could reduce the number of daily doses and [...] L'articolo Parkinson's disease, neurologist Stores: Ne…
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
